EW
USDEdwards Lifesciences Corporation Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$83.050
Kõrge
$84.830
Madal
$82.890
Maht
2.64M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
49.4B
Tööstusharu
Meditsiiniseadmed
Riik
United States
Kauplemisstatistika
Keskmine maht
4.58M
Börs
NYQ
Valuuta
USD
52 nädala vahemik
Seotud uudised
Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $90
Truist Securities analyst Richard Newitter maintains Edwards Lifesciences with a Hold and raises the price target from $87 to $90.
Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $99
Barclays analyst Matt Miksic maintains Edwards Lifesciences with a Overweight and raises the price target from $95 to $99.
Citigroup Maintains Buy on Edwards Lifesciences, Raises Price Target to $96
Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences with a Buy and raises the price target from $95 to $96.
JP Morgan Maintains Neutral on Edwards Lifesciences, Raises Price Target to $90
JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences with a Neutral and raises the price target from $85 to $90.
Goldman Sachs Maintains Buy on Edwards Lifesciences, Raises Price Target to $104
Goldman Sachs analyst David Roman maintains Edwards Lifesciences with a Buy and raises the price target from $94 to $104.
Piper Sandler Reiterates Overweight on Edwards Lifesciences, Raises Price Target to $95
Piper Sandler analyst Adam Maeder reiterates Edwards Lifesciences with a Overweight and raises the price target from $90 to $95.
RBC Capital Maintains Outperform on Edwards Lifesciences, Raises Price Target to $95
RBC Capital analyst Shagun Singh maintains Edwards Lifesciences with a Outperform and raises the price target from $89 to $95.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.